Is InMed Pharmaceuticals Inc. stock a buy or sell right now?

Based on current indicators, InMed Pharmaceuticals Inc. shows a Buy signal, supported by strong momentum and a confirmed uptrend.

What is InMed Pharmaceuticals Inc.’s RSI?

RSI is 86.42, indicating overbought levels and potential for a pullback.

What does MACD indicate for INM?

MACD at 0.05 signals bullish momentum with buyers in control.

What are InMed Pharmaceuticals Inc.’s key support and resistance levels?

Support sits around $0.36, while resistance is near $1.12. A breakout above $1.12 would open the door for further upside.

InMed Pharmaceuticals Inc.

INM•NASDAQ

Healthcare

Biotechnology

$1.60

$0.92(135.05%)

U.S. Market opens in NaNh NaNm

InMed Pharmaceuticals Inc. (INM) Stock Technical Analysis & Trading Signals

Live technical indicators, trading signals, and momentum insights for InMed Pharmaceuticals Inc. (NASDAQ:INM).

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

INM Technical Analysis Summary

InMed Pharmaceuticals Inc. stock currently shows a bullish trend, supported by momentum and strong buying pressure.

Overall Sentiment:Buy

Momentum:Bullish to Bearish Risk (RSI: 86.42)

Trend Strength:Moderate (ADX: 21.58)

Volatility:High (ATR: 0.13)

Support/Resistance:$0.36 – $1.12 (Bollinger Bands)

Overall, InMed Pharmaceuticals Inc. remains neutral, with indicators showing mixed momentum.

Momentum Indicators

RSI (14): 86.42

Bearish

Overbought, selling pressure may emerge.

Stochastic %K: 40.67

Neutral

Mid-range signal with no clear trend.

Williams %R: -20.51

Bullish

Buying pressure building steadily.

Rate of Change (ROC): 121.11

Strongly Bullish

Strong upside momentum.

Takeaway:InMed Pharmaceuticals Inc. shows steady upward momentum, supported by improving signals.

Trend & Volatility

MACD: 0.05

Bullish

Bullish, trend momentum is strengthening.

ADX: 21.58

Moderate

Moderate trend, direction gaining strength.

ATR (14): 0.13

Low

Low volatility, stable price action.

CCI (14): 466.67

Bearish Risk

Bearish risk, overbought levels suggest caution.

Takeaway:InMed Pharmaceuticals Inc. shows a firm trend supported by momentum, though one signal suggests caution.

Support & Resistance indicators

Bollinger Bands

Upper Band

$1.12

Middle Band (SMA 20)

$0.74

Lower Band

$0.36

Current Position

Above Upper Band

Takeaway:InMed Pharmaceuticals Inc. trades near the upper band, signaling overbought conditions and risk of pullback.

Keltner Channels

Upper Channel

$1.04

Middle Line (EMA 20)

$0.77

Lower Channel

$0.50

Squeeze Status

No Squeeze

Takeaway:InMed Pharmaceuticals Inc. trades near the upper channel, signaling resistance and risk of pullback.

Volume & Money Flow Analysis

On-Balance Volume88.77M

Money Flow Index99.93Bearish risk, overbought conditions may trigger pullback.

Relative Vigor Index74.32Bullish, price momentum strongly favors buyers.

Overall Takeaway:INM shows overheated money flow, with risk of pullback from overbought conditions.

Technical Trading Signals Summary

Based on the current technical analysis of InMed Pharmaceuticals Inc., here are the key trading signals and recommendations:

Bullish Signals

RSI above 50 → positive momentum from buyers.

MACD above 0 → bullish trend confirmation.

ADX above 20 → strong underlying trend.

Price trading above middle Bollinger Band → mid-term support intact.

Bearish Signals

Price near upper Bollinger Band → potential resistance and pullback risk.

MFI above 80 → overbought conditions may limit upside.

Overall Recommendation:InMed Pharmaceuticals Inc. currently shows a Buy with caution signal — momentum and trend strength are positive, but price is close to resistance and may face short-term pullbacks.